BETTER THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.008 USD | -11.11% |
|
-20.00% | -95.90% |
| Mar. 21 | Better Therapeutics, Inc. Receives Notice of Default from Hercules Capital, Inc | CI |
| Mar. 20 | Better Therapeutics, Inc.(NasdaqCM:BTTX) dropped from S&P TMI Index | CI |
Chart calendar Better Therapeutics, Inc.
0.4CHRLxoa7E8CbShewLnq9-MmibcXgPGgsyWrNG8KXWQ.mVOkbHF-2wNOXmwfmvW-rtto0_xTt76N_2nyXV9dFC-PV7lwb1-uFk8AcQ~e731de97208726e31445b52295a59e61
Upcoming events on Better Therapeutics, Inc.
Past events on Better Therapeutics, Inc.
| 2024-03-26 | Q4 2023 Earnings Release (Projected) |
| 2024-03-05 | Advanced Technologies & Treatments for Diabetes International Conference |
| 2023-11-09 08:30 am | Q3 2023 Earnings Call |
| 2023-11-09 07:00 am | Q3 2023 Earnings Release |
| 2023-10-30 08:00 am | Extraordinary Shareholders Meeting |
| 2023-08-09 04:30 pm | Q2 2023 Earnings Call |
| 2023-08-09 04:03 pm | Q2 2023 Earnings Release |
| 2023-07-11 08:30 am | AspyreRx™ FDA Approval Call |
| 2023-06-22 | European Association for the Study of the Liver Congress - Poster Number 818 |
| 2023-06-07 12:00 pm | Annual General Meeting |
| 2023-05-11 08:30 am | Q1 2023 Earnings Call |
| 2023-05-11 07:30 am | Q1 2023 Earnings Release |
| 2023-03-30 08:30 am | Q4 2022 Earnings Call |
| 2023-03-30 07:30 am | Q4 2022 Earnings Release |
| 2023-03-06 11:10 am | Cowen Health Care Conference |
| 2023-02-13 | BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference |
| 2022-12-08 08:30 am | LivVita Study Results Call |
| 2022-11-21 02:00 pm | BTIG Digital Health Forum |
| 2022-11-14 04:30 pm | Q3 2022 Earnings Call |
| 2022-11-14 04:01 pm | Q3 2022 Earnings Release |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -30,6 -28,3 -7.8% | -38,3 -41,3 7.28% | -27,1 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -40,5 -34,8 -16.51% | -39,8 -42,7 6.89% | -28,7 |
|
Net income Million USD | Released Forecast Spread | -6,39 | -40,3 -34,8 -16.07% | -39,8 -42,7 6.88% | -28,7 |
|
EPS USD | Released Forecast Spread | -2,05 | -3,11 -1,47 -111.56% | -1,69 -1,81 6.63% | -0,81 |
| Announcement Date | 23/04/21 | 28/03/22 | 30/03/23 | - |
Quarterly results
| Fiscal Period | December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -0,24 -8,53 97.18% | -12,1 -9,50 -27.41% | -9,35 -10,9 14.27% | -9,60 -11,7 17.87% | -11,0 -11,3 2.71% | -8,32 -11,3 26.65% | -8,93 -26,3 66.05% | -7,03 -7,09 0.89% | -5,34 -7,10 24.77% | -5,80 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -0,24 -9,46 97.47% | -13,9 -8,01 -73.52% | -9,66 -11,1 12.95% | -9,93 -11,9 16.57% | -11,4 -11,6 1.35% | -8,76 -11,7 25.11% | -9,36 -8,60 -8.79% | -7,59 -7,40 -2.51% | -5,86 -7,30 19.74% | -5,90 |
|
Net income Million USD | Released Forecast Spread | -0,24 -9,86 97.58% | -13,9 -8,13 -70.81% | -9,66 -11,1 12.95% | -9,93 -11,9 16.57% | -11,4 -11,6 1.32% | -8,77 -11,7 25.08% | -9,36 -8,60 -8.8% | -7,59 -7,40 -2.52% | -5,86 -7,30 19.7% | -5,90 |
|
EPS USD | Released Forecast Spread | -0,03 -1,87 98.4% | -0,71 -0,35 -102.86% | -0,41 -0,39 -6.49% | -0,42 -0,42 0% | -0,48 -0,45 -6.67% | -0,37 -0,50 26% | -0,39 -0,31 -27.87% | -0,24 -0,31 23.2% | -0,15 -0,20 23.08% | -0,12 |
| Announcement Date | 23/11/21 | 28/03/22 | 13/05/22 | 11/08/22 | 14/11/22 | 30/03/23 | 11/05/23 | 09/08/23 | 09/11/23 | - |
More events
Past sector events for Better Therapeutics, Inc.
| 2024-04-17 | HINOVA PHARMACEUTICALS INC.: Q4 2023 Earnings Release |
| 2024-04-17 02:07 am | TELIX PHARMACEUTICALS LIMITED: March 2024 Sales and Revenue Release - Activities Report |
| 2024-04-10 04:10 pm | PHARVARIS N.V.: Q4 2023 Earnings Release |
| 2024-04-10 01:22 am | POLARIS GROUP: March 2024 Sales and Revenue Release |
| 2024-04-02 02:30 am | ABIVAX: Q4 2023 Earnings Release |
| 2024-04-01 09:00 am | BIOMEA FUSION, INC.: Q4 2023 Earnings Release |
| 2024-03-28 10:42 pm | ALPHAMAB ONCOLOGY: Q4 2023 Earnings Release |
| 2024-03-28 04:28 pm | CENTESSA PHARMACEUTICALS PLC: Q4 2023 Earnings Release |
| 2024-03-28 04:05 pm | ARRIVENT BIOPHARMA, INC.: Q4 2023 Earnings Release |
| 2024-03-28 07:10 am | HANGZHOU TIGERMED CONSULTING CO., LTD: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- BTTX Stock
- Calendar Better Therapeutics, Inc.
